ArticleAPMIS : acta pathologica, microbiologica, et immunologica Scandinavica2025
Role of Systemic Inflammatory Markers in the Differential Diagnosis of Organizing Pneumonia and Lung Cancer.
Article in APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Distinguishing Organizing Pneumonia from Malignancy During Cancer Surveillance: Predominant Diagnostic Value of Imaging over Systemic Inflammatory Biomarkers.Current oncology (Toronto, Ont.) · 2026Article
- Predictors of ICU Length of Stay in Patients with Severe Pneumonia: A Six-Year Retrospective Cohort Study Focusing on Traditional Chinese Medicine Adjuvant Therapy.International journal of general medicine · 2026Article
- Blood-based inflammatory biomarkers in ovarian cancer: addressing the challenge of early detection, metastasis, and prognostic stratification.Oncology reviews · 2026Review
- Role of Systemic Inflammatory Markers in the Differential Diagnosis of Organizing Pneumonia and Lung Cancer.APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To investigate novel inflammatory indexes including neutrophil-to-lymphocyte ratio (NLR), systemic immune inflammation index (SII), systemic immune response index (SIRI), and pan-immune-inflammation value (PIV) in the diagnosis of organizing pneumonia (OP) and distinguishing OP from lung cancer (LC). The study included 125 patients with LC and 21 patients with OP. Retrospectively, we compared the values of SII, SIRI, PIV, NLR, and C-reactive protein (CRP) and evaluated correlations between the patient groups. The CRP levels in patients with OP (median: 45.2 mg/dL) were lower than those in patients with LC (median: 64 mg/dL). However, no differences were observed in systemic inflammatory indexes between the groups. Statistically significant positive correlations were found between neutrophils and NLR (r = 0.63), SIRI (r = 0.52), and SII (r = 0.72). In addition, significant negative correlations were observed between lymphocytes and NLR (r = -0.67), SIRI (r = -0.53), SII (r = -0.27), and PIV (r = -0.37). Increased CRP levels may indicate lung carcinoma risk and CRP measurements may be predictive in distinguishing between OP and LC. Additionally, high neutrophil counts, thrombocyte counts and/or lymphocytopenia might lead to a poor immune response and are linked to higher systemic inflammatory indices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.